The speakers will discuss what is currently known about genomic drivers of heart failure and opportunities for novel therapeutics being explored in their own research programs.
TORONTO (PRWEB) February 02, 2021
Heart failure is a significant global health issue. More than half of the people who develop heart failure die within five years. Current treatments do not help the largest group of these patients – those with heart failure with preserved ejection fraction (HFpEF) – and have limited effectiveness for those with reduced injection fraction (HFrEF).
HFpEF has been called the greatest unmet need in cardiovascular disease given the number of heart failure deaths per year and the proportion of patients with HFpEF. Despite significant research into the drivers of heart failure, many patients remain undiagnosed or poorly managed and new therapies are needed.
This webinar will cover recent advances in heart failure genomics with a focus on translating findings into improved therapeutics and diagnosis. Genuity Science and their colleagues are building large-scale real-world datasets combining whole-genome sequencing and detailed longitudinal clinical data from thousands of participants. For heart failure, these datasets help scientists discover and validate new drug targets for heart failure and are enriched with participants with HFpEF. Additionally, the speakers will discuss what is currently known about genomic drivers of heart failure and opportunities for novel therapeutics being explored in their own research programs.
Join guest speakers Benoit Tyl, MD, FESC, Medical and Scientific Director, Cardiology, Servier; Marc Semigran, MD, Senior Vice President, Medical Sciences, Myokardia; Irene Blat, PhD, Senior Director of Data Products and Analytics, Genuity Science; and webinar host Ellen Gordon, PhD, Vice President, Business Development, Genuity Science for the live webinar on Tuesday, February 23, 2021 at 10am EST (3pm GMT/UK).
For more information, or to register for this event, visit Genomic Advances in Heart Failure.
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.